SCOTTSDALE, AZ, March 08, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE–Â CBD Life SciencesÂ Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc., has now finalized the formulization for and is launching an organic – GMO free – CBD based anti-aging product line. The product line includes: anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream.Â
The GlobalÂ Anti-Aging MarketÂ was worth $42.51 Billion in 2018 and estimated to $55.03 Billion by 2023. LBC Bioscience, Inc. is positioning itself to be a leader in CBD based anti-aging and is already in talks with a number of companies to âwhite label’ the product line.Â
In addition, LBC Bioscience, Inc. is working with Dr. Farhan TaghizadehÂ of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line. Arizona Facial Plastics is a leading cosmetic surgery based in Phoenix, Arizona. Â
About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol âOCSYD’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.
About LBC Bioscience Inc.Â Â
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils,Â recovery pain relief creams, anxiety and sleep solutions, supplements, edibles, and a full line of pet products.Â In addition, LBC is in the process of developing an anti-aging skin product line. LBC’s products can be viewed and purchased on the company’s website atÂ www.lbcbioscienceinc.com.
Ten Associates LLC
11529 N. 120th St.
Contact: Thomas E. Nelson
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Optium Cyber Systems, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Source: CBD Life Sciences Inc.